CN112043893A - In-vitro citric acid anticoagulation hemodialysis control device, system and method - Google Patents
In-vitro citric acid anticoagulation hemodialysis control device, system and method Download PDFInfo
- Publication number
- CN112043893A CN112043893A CN202010975237.7A CN202010975237A CN112043893A CN 112043893 A CN112043893 A CN 112043893A CN 202010975237 A CN202010975237 A CN 202010975237A CN 112043893 A CN112043893 A CN 112043893A
- Authority
- CN
- China
- Prior art keywords
- hemodialysis
- module
- control
- citric acid
- infusion pump
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 title claims abstract description 153
- 238000001631 haemodialysis Methods 0.000 title claims abstract description 114
- 230000000322 hemodialysis Effects 0.000 title claims abstract description 113
- 238000000338 in vitro Methods 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 24
- 230000010100 anticoagulation Effects 0.000 title claims description 43
- 238000001802 infusion Methods 0.000 claims abstract description 43
- 230000003993 interaction Effects 0.000 claims abstract description 21
- 238000006243 chemical reaction Methods 0.000 claims abstract description 18
- 238000005516 engineering process Methods 0.000 claims abstract description 12
- 238000012545 processing Methods 0.000 claims abstract description 9
- 238000005086 pumping Methods 0.000 claims abstract description 9
- 239000003146 anticoagulant agent Substances 0.000 claims abstract description 6
- 229940127219 anticoagulant drug Drugs 0.000 claims abstract description 6
- 238000000502 dialysis Methods 0.000 claims abstract description 5
- 238000012546 transfer Methods 0.000 claims description 15
- 230000010354 integration Effects 0.000 claims description 3
- 239000000004 hemodialysis solution Substances 0.000 claims 2
- 230000002452 interceptive effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract 2
- 206010062713 Haemorrhagic diathesis Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 208000031169 hemorrhagic disease Diseases 0.000 description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 2
- 229960001008 heparin sodium Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000013038 Hypocalcemia Diseases 0.000 description 1
- 206010051077 Post procedural haemorrhage Diseases 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- -1 calcium citrate compound Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 230000000705 hypocalcaemia Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1621—Constructional aspects thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- G—PHYSICS
- G05—CONTROLLING; REGULATING
- G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
- G05B19/00—Programme-control systems
- G05B19/02—Programme-control systems electric
- G05B19/04—Programme control other than numerical control, i.e. in sequence controllers or logic controllers
- G05B19/042—Programme control other than numerical control, i.e. in sequence controllers or logic controllers using digital processors
- G05B19/0423—Input/output
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Emergency Medicine (AREA)
- Physics & Mathematics (AREA)
- Automation & Control Theory (AREA)
- General Physics & Mathematics (AREA)
- External Artificial Organs (AREA)
Abstract
The invention discloses an in vitro citric acid anticoagulant hemodialysis liquid dialysis control device, a system and a method, comprising a hemodialysis machine and an infusion pump which are integrally formed, a pipeline component for connecting the hemodialysis machine and the infusion pump, and a control part for control and interaction; the data information of the control modules of the hemodialysis machine and the infusion pump is acquired through the data acquisition module of the control part, converted through the digital-to-analog conversion module and then input into the processor module for processing and calculation, and the mode selection module can set and control the hemodialysis machine and the infusion pump; the dialysis control device, the system and the method for the in-vitro citric acid anticoagulant hemodialysis liquid effectively combine a hemodialysis machine with an infusion pump, carry out interaction and control through an integrated control system, combine the hemodialysis system and a citric acid pumping system, and are convenient for hemodialysis popularization and application by using a local citric acid anticoagulant technology.
Description
Technical Field
The invention relates to the technical field of hemodialysis, in particular to an in-vitro citric acid anticoagulation hemodialysis control device, system and method.
Background
In the hemodialysis treatment, an anticoagulant is required to be applied in an auxiliary manner to ensure the normal function of extracorporeal circulation, the anticoagulant is an important link in the hemodialysis, and the effect is obvious by mainly using a heparin sodium medicament; however, for patients with bleeding tendency, the bleeding tendency is easily increased during the anticoagulation period of heparin sodium, in recent years, the in vitro citric acid anticoagulation technology is clinically used in hemodialysis, and the technology is significant in preventing bleeding especially for patients with obvious bleeding tendency and needing hemodialysis in the perioperative period; citric acid is used for anticoagulation in vitro in hemodialysis, has obvious effect in a blood coagulation mechanism, and can combine calcium ions to form a calcium citrate compound in a circulation pipeline during hemodialysis, so that the calcium ion concentration is reduced, the blood coagulation time is prolonged, and the blood coagulation occurrence rate is reduced. When hemodialysis is finished, calcium ions are supplemented, the occurrence of hypocalcemia is prevented, and the hemodialysis effect is improved; research shows that the hemodialysis is safe and reliable by using an in-vitro citric acid anticoagulation technology, has a bleeding risk obviously lower than that of the anticoagulation in heparin, is worthy of clinical popularization and application, and is particularly suitable for patients with definite bleeding tendency and postoperative dialysis in clinic.
At present, when the extracorporeal citric acid anticoagulation hemodialysis technology is applied, as hemodialysis equipment does not have the function of pumping, in the actual operation process, an additional infusion pump is needed to pump and monitor citric acid, so that the technology is inconvenient to operate in the application process, and the hemodialysis equipment cannot be effectively combined with citric acid pumping equipment, therefore, the applicant designs an extracorporeal citric acid anticoagulation hemodialysis control device, system and method.
Disclosure of Invention
Aiming at the problems in the prior art, the invention provides an in-vitro citric acid anticoagulation hemodialysis control device, system and method, which combine a hemodialysis system and a citric acid pumping system and are convenient for hemodialysis popularization and application by using a local citric acid anticoagulation technology.
In order to achieve the technical purpose and achieve the technical effect, the invention is realized by the following technical scheme:
the utility model provides an external citric acid anticoagulation hemodialysis controlling means, includes hemodialysis machine, transfer pump, pipeline subassembly and control part, hemodialysis machine and transfer pump integrated into one piece, the transfer pump is integrated to be installed in hemodialysis machine both sides, and hemodialysis machine and transfer pump pass through pipeline subassembly and each access connection, hemodialysis machine and the control module integration of transfer pump are in control part to realize alternately and information feedback through mutual module.
Further, the interaction module comprises a display module, an input module and a voice module, and all the modules are connected with the control part;
the display module is a touch display screen, displays the hemodialysis machine and the infusion pump in a split screen mode, and performs mode selection, interaction and information feedback at the same time.
Further, the pipe assemblies of the hemodialysis machine and the infusion pump are respectively provided with marks.
Furthermore, the infusion pump at least comprises one infusion pump which is arranged on the left side and the right side of the hemodialysis machine.
Another objective of the present invention is to provide a control system of an extracorporeal citric acid anticoagulation hemodialysis control device;
the control system includes:
a data acquisition module: the system is used for acquiring data information of a control module of the hemodialysis machine and a control module of the infusion pump;
a digital-to-analog conversion module: the data acquisition device is used for converting the acquired data information;
the processor module: the digital-to-analog conversion module is used for converting the digital-to-analog conversion module according to a preset program and parameters and inputting the converted digital-to-analog conversion module into the processor module for processing and calculation;
a mode selection module: used for setting and controlling the hemodialysis machine and the infusion pump;
a human-computer interaction module: the method is used for realizing human-computer interaction.
Furthermore, a data acquisition module of the control system acquires data information of a control module of the hemodialysis machine and the infusion pump, the data information is converted by a digital-to-analog conversion module and then input into a processor module for processing and calculation, and a mode selection module can set and control the hemodialysis machine and the infusion pump.
The other purpose of the invention is to provide an in vitro citric acid anticoagulation hemodialysis control method;
the control method comprises the following steps:
manual control: controlling a hemodialysis machine and an infusion pump through a human-computer interaction module according to the parameter requirements of hemodialysis and local citric acid anticoagulation pumping;
automatic control: and carrying out mode selection according to a preset mode selection module to control the hemodialysis machine and the infusion pump.
The invention also aims to provide an application of the device, the system and the method for controlling the in-vitro citric acid anticoagulation hemodialysis in the in-vitro citric acid anticoagulation hemodialysis technology.
The invention has the beneficial effects that:
the invention relates to an in vitro citric acid anticoagulation hemodialysis control device, a system and a method, which comprises a hemodialysis machine and a transfusion pump which are integrally formed, a pipeline component for connecting the hemodialysis machine and the transfusion pump, and a control part for control and interaction; the data information of the control modules of the hemodialysis machine and the infusion pump is acquired through the data acquisition module of the control part, converted through the digital-to-analog conversion module and then input into the processor module for processing and calculation, and the mode selection module can set and control the hemodialysis machine and the infusion pump;
the device, the system and the method for controlling the in-vitro citric acid anticoagulation hemodialysis effectively combine a hemodialysis machine with an infusion pump, carry out interaction and control through an integrated control system, combine a hemodialysis system and a citric acid pumping system, and are convenient for hemodialysis popularization and application by using a local citric acid anticoagulation technology.
Of course, it is not necessary for any product in which the invention is practiced to achieve all of the above-described advantages at the same time.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings used in the description of the embodiments will be briefly introduced below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is obvious for those skilled in the art that other drawings can be obtained according to the drawings without creative efforts.
FIG. 1 is a schematic structural diagram of an extracorporeal citric acid anticoagulation hemodialysis control device according to an embodiment of the present invention;
FIG. 2 is a schematic control diagram of the extracorporeal citric acid anticoagulation hemodialysis control device according to the embodiment of the present invention;
FIG. 3 is a block diagram illustrating the control principle of the extracorporeal citric acid anticoagulation hemodialysis control device according to the embodiment of the present invention;
in the drawings, the names of the components represented by the respective reference numerals are as follows:
1-hemodialysis machine, 2-infusion pump.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
As shown in fig. 1
The utility model provides an external citric acid anticoagulation hemodialysis controlling means, includes hemodialysis machine, transfer pump, pipeline subassembly and control part, hemodialysis machine and transfer pump integrated into one piece, the transfer pump is integrated to be installed in hemodialysis machine both sides, and hemodialysis machine and transfer pump pass through pipeline subassembly and each access connection, hemodialysis machine and the control module integration of transfer pump are in control part to realize alternately and information feedback through mutual module.
The interaction module comprises a display module, an input module and a voice module, and all the modules are connected with the control part;
the display module is a touch display screen, displays the hemodialysis machine and the infusion pump in a split screen mode, and performs mode selection, interaction and information feedback at the same time.
The hemodialysis machine and the infusion pump are respectively provided with marks.
The infusion pump at least comprises one infusion pump which is arranged on the left side and the right side of the hemodialysis machine.
Example 2
A control system of an in vitro citric acid anticoagulation hemodialysis control device;
the control system includes:
a data acquisition module: the system is used for acquiring data information of a control module of the hemodialysis machine and a control module of the infusion pump;
a digital-to-analog conversion module: the data acquisition device is used for converting the acquired data information;
the processor module: the digital-to-analog conversion module is used for converting the digital-to-analog conversion module according to a preset program and parameters and inputting the converted digital-to-analog conversion module into the processor module for processing and calculation;
a mode selection module: used for setting and controlling the hemodialysis machine and the infusion pump;
a human-computer interaction module: the method is used for realizing human-computer interaction.
The data acquisition module of the control system acquires data information of the control modules of the hemodialysis machine and the infusion pump, the data information is converted by the digital-analog conversion module and then input into the processor module for processing and calculation, and the mode selection module can set and control the hemodialysis machine and the infusion pump.
Example 3
An in vitro citric acid anticoagulation hemodialysis control method;
the control method comprises the following steps:
manual control: controlling a hemodialysis machine and an infusion pump through a human-computer interaction module according to the parameter requirements of hemodialysis and local citric acid anticoagulation pumping;
automatic control: and carrying out mode selection according to a preset mode selection module to control the hemodialysis machine and the infusion pump.
Example 4
An in vitro citric acid anticoagulation hemodialysis control device, a system and an application of the method in the in vitro citric acid anticoagulation hemodialysis technology.
The invention relates to an in vitro citric acid anticoagulation hemodialysis control device, a system and a method, which comprises a hemodialysis machine and a transfusion pump which are integrally formed, a pipeline component for connecting the hemodialysis machine and the transfusion pump, and a control part for control and interaction; the data information of the control modules of the hemodialysis machine and the infusion pump is acquired through the data acquisition module of the control part, converted through the digital-to-analog conversion module and then input into the processor module for processing and calculation, and the mode selection module can set and control the hemodialysis machine and the infusion pump;
the device, the system and the method for controlling the in-vitro citric acid anticoagulation hemodialysis effectively combine a hemodialysis machine with an infusion pump, carry out interaction and control through an integrated control system, combine a hemodialysis system and a citric acid pumping system, and are convenient for hemodialysis popularization and application by using a local citric acid anticoagulation technology.
In the description herein, references to the description of "one embodiment," "an example," "a specific example" or the like are intended to mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention. In this specification, the schematic representations of the terms used above do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
The preferred embodiments of the invention disclosed above are intended to be illustrative only. The preferred embodiments are not intended to be exhaustive or to limit the invention to the precise embodiments disclosed. Obviously, many modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to best explain the principles of the invention and the practical application, to thereby enable others skilled in the art to best utilize the invention. The invention is limited only by the claims and their full scope and equivalents.
Claims (8)
1. An in vitro citric acid anticoagulation hemodialysis controlling device, which is characterized in that: including hemodialysis machine, transfer pump, pipeline subassembly and control part, hemodialysis machine and transfer pump integrated into one piece, the transfer pump is integrated to be installed in hemodialysis machine both sides, and hemodialysis machine and transfer pump pass through pipeline subassembly and each access connection, hemodialysis machine and the control module integration in control part of transfer pump to realize alternately and information feedback through interactive module.
2. The extracorporeal citric acid anticoagulation hemodialysis control device according to claim 1, wherein: the interaction module comprises a display module, an input module and a voice module, and all the modules are connected with the control part;
the display module is a touch display screen, displays the hemodialysis machine and the infusion pump in a split screen mode, and performs mode selection, interaction and information feedback at the same time.
3. The extracorporeal citric acid anticoagulation hemodialysis control device according to claim 1, wherein: the hemodialysis machine and the infusion pump are respectively provided with marks.
4. The extracorporeal citric acid anticoagulation hemodialysis control device according to claim 1, wherein: the infusion pump at least comprises one infusion pump which is arranged on the left side and the right side of the hemodialysis machine.
5. A control system for an extracorporeal citric acid anticoagulation hemodialysis control apparatus according to any one of claims 1-4, wherein:
the control system includes:
a data acquisition module: the system is used for acquiring data information of a control module of the hemodialysis machine and a control module of the infusion pump;
a digital-to-analog conversion module: the data acquisition device is used for converting the acquired data information;
the processor module: the digital-to-analog conversion module is used for converting the digital-to-analog conversion module according to a preset program and parameters and inputting the converted digital-to-analog conversion module into the processor module for processing and calculation;
a mode selection module: used for setting and controlling the hemodialysis machine and the infusion pump;
a human-computer interaction module: the method is used for realizing human-computer interaction.
6. The control system of the extracorporeal citric acid anticoagulation hemodialysis control device according to claim 5, wherein: the data acquisition module of the control system acquires data information of the control modules of the hemodialysis machine and the infusion pump, the data information is converted by the digital-analog conversion module and then input into the processor module for processing and calculation, and the mode selection module can set and control the hemodialysis machine and the infusion pump.
7. A control system of the extracorporeal citric acid anticoagulation hemodialysis control device according to claim 6, characterized in that:
the dialysis control method of the in-vitro citric acid anticoagulant hemodialysis solution comprises the following steps:
manual control: controlling a hemodialysis machine and an infusion pump through a human-computer interaction module according to the parameter requirements of hemodialysis and local citric acid anticoagulation pumping;
automatic control: and carrying out mode selection according to a preset mode selection module to control the hemodialysis machine and the infusion pump.
8. An in vitro citric acid anticoagulation hemodialysis control device, a system and an application of the method in an in vitro citric acid anticoagulation hemodialysis solution dialysis technology.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010975237.7A CN112043893A (en) | 2020-09-16 | 2020-09-16 | In-vitro citric acid anticoagulation hemodialysis control device, system and method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010975237.7A CN112043893A (en) | 2020-09-16 | 2020-09-16 | In-vitro citric acid anticoagulation hemodialysis control device, system and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112043893A true CN112043893A (en) | 2020-12-08 |
Family
ID=73603001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010975237.7A Pending CN112043893A (en) | 2020-09-16 | 2020-09-16 | In-vitro citric acid anticoagulation hemodialysis control device, system and method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112043893A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050085760A1 (en) * | 2003-10-15 | 2005-04-21 | Ware Lee C. | Medical fluid therapy flow balancing and synchronization system |
| US20100121246A1 (en) * | 2008-11-03 | 2010-05-13 | Transvivo Inc. | Modular hemofiltration apparatus with interactive operator instructions and control system |
| CN104471579A (en) * | 2013-03-15 | 2015-03-25 | 甘布罗伦迪亚肾脏产品公司 | Extracorporeal Blood Treatment Fluids Interface |
| CN107045588A (en) * | 2016-02-08 | 2017-08-15 | B·布莱恩·阿维图姆股份公司 | Method for setting fluid processing medical equipment |
-
2020
- 2020-09-16 CN CN202010975237.7A patent/CN112043893A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050085760A1 (en) * | 2003-10-15 | 2005-04-21 | Ware Lee C. | Medical fluid therapy flow balancing and synchronization system |
| US20100121246A1 (en) * | 2008-11-03 | 2010-05-13 | Transvivo Inc. | Modular hemofiltration apparatus with interactive operator instructions and control system |
| CN104471579A (en) * | 2013-03-15 | 2015-03-25 | 甘布罗伦迪亚肾脏产品公司 | Extracorporeal Blood Treatment Fluids Interface |
| CN107045588A (en) * | 2016-02-08 | 2017-08-15 | B·布莱恩·阿维图姆股份公司 | Method for setting fluid processing medical equipment |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105517490A (en) | Full-automatic regional citrate anticoagulation machine | |
| CN112043893A (en) | In-vitro citric acid anticoagulation hemodialysis control device, system and method | |
| Kim et al. | The effect of increasing blood flow rate on dialysis adequacy in hemodialysis patients with low Kt/V | |
| Farah et al. | Combination hemodialysis and centrifugal therapeutic plasma exchange: 18 years of C anadian experience | |
| CN106267408A (en) | A kind of full-automatic Regional Citrate Anticoagulation device | |
| CN110960742B (en) | RCA control system and RCA target control infusion pump | |
| CN112717218A (en) | Newborn blood exchange system | |
| CN117679573A (en) | In-vitro citric acid anticoagulation control system | |
| CN113230531A (en) | System and method for connecting additional pressure adjusting device in ECMO and CRRT pipelines | |
| CN207679849U (en) | A kind of coronary angiography tetrad three-way pipe | |
| Yamashita et al. | Blood compatibility and filtration: characteristics of newly developed polyester polymer alloy membrane | |
| CN216496772U (en) | Newborn blood exchange system | |
| CN216258496U (en) | Equipment for realizing continuous slow blood purification treatment | |
| CN113368328B (en) | Blood purifying equipment with built-in intelligent citric acid anticoagulation technology | |
| CN115910280A (en) | Auxiliary system and method for regional citric acid anticoagulation of CRRT | |
| CN102716518A (en) | Blood purification equipment with citrate anticoagulant device | |
| Sulayman et al. | DESIGN AND DEVELOPMENT OF ARDUINO-BASED TEMPERATURE MONITORING SYSTEM FOR A PORTABLE HAEMODIALYSIS SYSTEM | |
| CN117339041A (en) | Equivalent conversion method of citric acid and application thereof | |
| CN115252936A (en) | Blood purification equipment and storage medium | |
| Troidle et al. | Why do so many patients have a Dialysis Catheter and not arteriovenous fistulae or grafts? | |
| Gabauer et al. | Initial clinical experience with cardiopulmonary bypass and auto-oxygenation | |
| Christopoulou | Hemodialysis in the Elderly | |
| Kroeker et al. | Return on investment: an economic guideline for selecting home daily/nocturnal hemodialysis patients | |
| Lockridge et al. | 6 Years of Experience with Nightly Home Hemodialysis Access | |
| Seyrek et al. | Is There Any Relationship between Serum Levels of IL‐10 and Atherosclerosis in Hemodialysis Patients? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201208 |